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Abstract: Withania somnifera (Ashwagandha) root extract is an important herbal medicine. The current study was designed 
to investigate the impact of Consciousness Energy Healing Treatment (The Trivedi Effect
®
) on the characteristic properties of 
the phytoconstituents present in the ashwagandha root extract using LC-MS, GC-MS, and NMR spectroscopy. Ashwagandha 
root extract was divided into two parts – one part was control (without treatment), while another part was treated with the 
Consciousness Energy Healing Treatment remotely by seven renowned Biofield Energy Healers and defined as the Biofield 
Energy Treated sample. The LC-MS analysis revealed that the retention time (Rt) of the phytoconstituents remained same in 
both the control and treated samples, whereas the peak area% was significantly altered. The peak area% of the treated sample 
at Rt of 5.06, 5.24, 5.49, 5.68, 6.78, 6.87, 8.12, 8.22, 8.36, 8.55, 9.02, and 10.13 minutes were significantly increased in the 
range of 0.27% to 146.94% compared to the control sample. In addition, the peak area% of the treated sample at Rt of 5.29, 
5.36, 6.40, 6.49, 6.56, 6.67, 7.08, 7.37, 7.76, 7.87, 8.02, 8.43, 8.85, 8.97, and 9.12 minutes were significantly decreased in the 
range of 1.83% to 23.53% compared with the control sample. A total of 18 withanolides such as sitoindoside IX, viscosa 
lactone B, 24, 25-dihydrowithanolide D, withanolide A, withanone, withaferin A, withanolide D, ixocarpalactone A, 
withanolide S, withanolide sulfoxide, etc. were proposed with their structure from the molecular mass at m/z 650, 489, 473, 
471, 505, and 992 at retention times of 6.87, 7.10, 7.87, 8.22, 8.54, and 9.11 minutes with the help of GC-MS and NMR data of 
both the control and Biofield Energy Treated samples. The mass peak intensity values of the Biofield Energy Treated sample at 
the same retention time in was significantly decreased in the range of 3.99% to 52.28% compared with the control sample. 
These findings suggest that Energy of Consciousness Healing Treatment could be beneficial for altering the concentration of 
the phytoconstituents in the ashwagandha root extract by modifying their intrinsic physicochemical properties, which might be 
helpful to improve the bioavailability of active constituents of ashwagandha root extract that might provide better therapeutic 
response against inflammatory diseases, immunological disorders, arthritis, cancer, diabetes, sexual disorders, aging and other 
chronic infections. 
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®
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1. Introduction 
Worldwide phyto-medicines have the huge demand for the 
prevention of various diseases and better quality of life due to 
their impressive therapeutic effects and fewer side effects 
compared to the modern medicines [1]. Ashwagandha is an 
ancient Rasayana herb and is popularly known as 
‘Ashwagandha’ or winter cherry or ‘Indian ginseng’ [2, 3]. 
Ashwagandha is mostly used in the preparation of 
pharmaceuticals and nutraceuticals for the prevention and 
treatment of various diseases such as nervous system and 
sexual disorders, infectious diseases, diabetes, cancer, 
immunological disorders, stress, ulcer, arthritis, etc. It is also 
useful to arrest the aging process, rejuvenate the body and 
boost the body defense system against infectious disorders as 
well as to promote the longevity of life [2-6]. Ashwagandha 
root extract contains majorly oxygenated withanolides along 
with numerous sitoindosides, alkaloids, withanamides, 
reducing sugars, peroxidases, glycosides, starch, withanicil, 
benzyl alcohol, 2-phenyl ethanol, dilcitol, 3, 4, 5-trihydroxy 
cinnamic acid, benzoic acid phenyl acetic acid, etc. [7-9]. 
Isolated withanolides possess various pharmacological 
activities such as antioxidant, anticancer, neuroprotective, 
immunomodulating, anti-inflammatory, antiarthritic, 
hepatoprotective, antimicrobial, hypoglycaemic, etc. [10-12]. 
Thus, ashwagandha root extract was considered as one of the 
components in a novel proprietary herbomineral formulation 
which can be used as nutraceutical supplement for the 
prevention and treatment of various disorders. 
A unique vital force preserved by every living organisms 
which is usually believed to create the source of life is co-
related with the soul, spirit, and mind and is also recognized 
as prana by the Hindus, ki by the Japanese, and qi or chi by 
the Chinese from the ancient-time. Now-a-days, this 
hypothetical vital force is considered as the Bioenergetics 
Field. This energy field is infinite, paradimensional and 
dynamic electromagnetic field surrounding the human body. 
This is also known as The Biofield Energy. It can easily flow 
between the human and environment that leads to the 
continuous movement or matter of energy [13, 14]. Thus, the 
human has the capability to harness energy from the earth, 
the “Universal Energy Field” and transmit it to any living or 
nonliving object (s) around the globe. The objects always 
receive the energy and respond in a useful way. This process 
is known as Biofield Energy Healing Treatment [15-17]. 
Biofield (Putative Energy Fields) based Energy Therapies 
have been practiced worldwide in different health disease 
profiles [18]. The National Center of Complementary and 
Integrative Health (NCCIH) has been recognized and 
accepted Biofield Energy Healing as a Complementary and 
Alternative Medicine (CAM) health care approach in 
addition to other therapies, medicines and practices such as 
natural products, yoga, deep breathing, Tai Chi, 
chiropractic/osteopathic manipulation, Qi Gong, meditation, 
special diets, homeopathy, progressive relaxation, massage, 
guided imagery, acupressure, relaxation techniques, 
hypnotherapy, acupuncture, healing touch, movement 
therapy, pilates, mindfulness, rolfing structural integration, 
Ayurvedic medicine, traditional Chinese herbs and 
medicines, naturopathy, essential oils, aromatherapy, cranial 
sacral therapy, Reiki, and applied prayer (as is common in all 
religions, like Hinduism, Christianity, Buddhism and 
Judaism) [19]. The Trivedi Effect
®
 - Biofield Energy 
Treatment has been extensively studied with significant 
outcomes in many scientific fields such as cancer research 
[20]; altered antimicrobial sensitivity of pathogenic microbes 
in biotechnology [21, 22], genetics [23, 24], microbiology 
[25-27], changing the structure of the atom in relation to the 
various metals, ceramics, polymers and chemicals materials 
science [28-30], nutraceuticals [31, 32], pharmaceuticals [33, 
34], organic compounds [35-37], and improved overall 
growth and yield of plants in agricultural science [38, 39]. 
Modern sophisticated techniques such as high-
performance liquid chromatography (HPLC) with photodiode 
array and evaporative light scattering detection, ultra-
performance liquid chromatography (UPLC), electrospray 
ionization (ESI) normally hyphenated with mass 
spectrometry, gas chromatography (GC), nuclear magnetic 
resonance (NMR) are very useful for the metabolite profiling 
and identification of the crude herbal extract [8, 40-42]. The 
LC-MS, GC-MS and NMR analysis of ashwagandha root 
extract revealed the presence of several known withanolides 
including withaferin A, withanolide D, withanoside IV/VI, 
withanolide sulfoxide, etc. along with two new withanolides 
i.e. dihydrowithanolide D and ixocarpalactone A [43]. Thus, 
LC-MS, GC-MS, and NMR analysis were carried out for the 
profiling and structure elucidation of the phytoconstituents of 
the Consciousness Energy Healing Treated (The Trivedi 
Effect
®
) ashwagandha root extract. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Ashwagandha root extract was procured from Sanat 
Product Ltd, India. The HPLC grade acetonitrile and Milli Q 
water were purchased from Merck and Millipore. All other 
chemicals used in the experiment were of analytical grade 
available in India. 
2.2. Energy of Consciousness Healing Treatment Strategies 
Ashwagandha root extract powder was one of the 
components of the new proprietary herbomineral 
formulation, developed by our research team and it was used 
per se as the test compound for the current study. The test 
compound was divided into two parts, one part of the test 
compound was treated with Energy of Consciousness 
Healing Treatment (The Trivedi Effect
®
) by renowned 
Biofield Energy Healers and defined as Biofield Energy 
Treated sample. The second part of the test compound did not 
receive any sort of treatment and defined as untreated or 
control ashwagandha root extract sample. This Biofield 
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Energy Treatment was provided by the group of seven 
renowned Biofield Energy Healers who participated in this 
study and performed the Biofield Energy Treatment remotely. 
All seven Biofield Energy Healers were remotely located in 
the U.S.A., while the test compound was located in the 
research laboratory of GVK Biosciences Pvt. Ltd., 
Hyderabad, India. This Consciousness Energy Healing 
Treatment was provided for 5 minutes through Healer’s 
Unique Energy Transmission process remotely to the test 
compound under the laboratory conditions. None of the 
Biofield Energy Healers in this study visited the laboratory in 
person, nor had any contact with the compounds. Similarly, 
the control compound was subjected to “sham” healers for 5 
minutes, under the same laboratory conditions. The sham 
healer did not have any knowledge about the Consciousness 
Energy Healing Treatment. After that, the Biofield Energy 
Treated and untreated samples were kept in similar sealed 
conditions and characterized thoroughly by LC-MS, GC-MS 
and NMR spectroscopy. 
2.3. Characterization 
2.3.1. Liquid Chromatography Mass Spectrometry (LC-MS) 
The LC-MS analysis of the control and Biofield Energy 
Treated samples were conducted by following the almost 
same method as mentioned in the recent literature [43] using 
The Waters
®
 ACQUITY UPLC, Milford, MA, USA 
equipped with a binary pump (The Waters
®
 BSM HPLC 
pump), auto sampler, column heater and a photo-diode array 
(PDA) detector. A Triple Quad (Waters Quattro Premier XE, 
USA) mass spectrometer equipped with an electrospray 
ionization (ESI) source was used for the mass spectrometric 
analysis. The control and Biofield Energy Treated extract 
powders were dissolved in dimethyl sulfoxide to afford a 1 
mg/mL stock solution. An aliquot of 2 µL of the stock 
solution was used for LC-MS analysis with a total run time 
of 25 min. Mass spectra were recorded in the positive 
ionization mode and with the full scan (m/z 50-1400). 
Percent change in peak area (%), T was calculated using 
following equation (1): 
%	change	in	peak	area% =


× 100      (1) 
Where, TControl and TTreated are the peak area (%) of the 
control and Biofield Energy Treated samples, respectively. 
Similarly, the percent change in mass peak intensity (I) 
was calculated using equation (2): 
%	change	in	mass	peak	intensity =
#	#	
#	
× 100   (2) 
Where, IControl and ITreated are the mass peak intensity of the 
control and Biofield Energy Treated samples, respectively. 
2.3.2. Gas Chromatography-Mass Spectrometry (GC-MS) 
Analysis 
GC-MS analysis of the control and Biofield Energy 
Treated samples were analyzed by following the same 
procedure as mentioned in the recent scientific literature [43] 
with the help of Agilent 7890B with 5977A Mass selective 
detector, USA equipped with a Quadrupole detector with pre-
filter and flame ionization detector (FID). The control and 
Biofield Energy Treated extract powders were dissolved in 
dimethyl sulfoxide to afford a 1 mg/mL stock solution. An 
aliquot of 1.0 µL of the stock solution was injected with a 
total run time of 44.0 min. The identification of analyte was 
performed using the retention time with a comparison of the 
mass spectra of the identified substances with references. 
2.3.3. Nuclear Magnetic Resonance (NMR) Analysis 
1
H NMR and 
13
C NMR analysis of the control and Biofield 
Energy Treated samples extract powders were performed on
 
a 
400 MHZ VARIAN FT-NMR spectrometer and 100.00 MHz 
on a VARIAN FT-NMR spectrometer, respectively using the 
same procedure as mentioned in the recent literature [43]. 
1
H 
NMR multiplicities were labelled as singlet (s), doublet (d), 
doublet of doublet (dd), triplet (t), quartet (q), multiplet (m), 
broad (br), apparent (app). Chemical shifts (δ) were in parts 
per million (ppm) relative to the solvent’s residual proton 
chemical shift (CD3OD, δ = 3.31, 4.80 ppm) and solvent’s 
residual carbon chemical shift (CD3OD, δ = 49.15 ppm). 
3. Results and Discussion 
The LC chromatograms and their chromatographic data of 
the control and Biofield Energy Treated samples of 
ashwagandha root extract are presented in Figure 1. The 
chromatograms of the control and Biofield Energy Treated 
samples showed 27 peaks at different retention times (Figure 
1). There was no significant change in the retention time of 
the chromatographic peaks in the Biofield Energy Treated 
sample compared with the control sample indicated that the 
polarity of the phytoconstituents in ashwagandha root extract 
remained unaltered. 
The peak area and peak area% of the Biofield Energy 
Treated sample were significantly altered compared with the 
control sample (Table 1). The total peak area of the Biofield 
Energy Treated sample was significantly decreased by 
11.07% compared with the control sample. The changes in 
peak area% are calculated for the Biofield Energy Treated 
sample compared to the control sample. There was a 
significant increase in the peak area% of the Biofield Energy 
Treated sample in the range of 0.27% to 146.94% at Rt of 
5.06, 5.24, 5.49, 5.68, 6.78, 6.87, 8.12, 8.22, 8.36, 8.55, 9.02, 
and 10.13 minutes compared with the control sample. 
Consequently, the peak area% of the Biofield Energy Treated 
sample at Rt of 5.29, 5.36, 6.40, 6.49, 6.56, 6.67, 7.08, 7.37, 
7.76, 7.87, 8.02, 8.43, 8.85, 8.97, and 9.12 minutes were 
significantly decreased in the range of 1.83% to 23.53%, 
respectively compared to the control sample. The peak area% 
provides the relative amounts of components in the 
chromatogram, when all components respond in the detector 
and are eluted [43, 44]. Here, the liquid chromatographic 
conditions for both the control and Biofield Energy Treated 
samples were same. It is assumed that all the components in 
both the samples were equally responded in the detector. 
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Thus, the provided peak area% revealed the relative amounts 
of the phytoconstituents of ashwagandha root extract. The 
Biofield Energy Healing Treatment might have the 
significant effect on the relative amount of the 
phytoconstituents (Table 1). It is presumed that the intrinsic 
physicochemical properties of ashwagandha root extract such 
as particle size, shape, etc. of the compounds that are related 
to the solubility of the compounds might alter due to the 
Biofield Energy Healing Treatments [28-35]. 
 
Figure 1. Liquid chromatograms of the control and Biofield Energy Treated Ashwagandha root extract. 
Table 1. Liquid chromatographic data of the control and Biofield Energy Treated Ashwagandha root extract. 
WS-Control WS-Biofield Energy Treated 
% Change in PA%* 
Rt PA PA% Rt PA PA% 
5.07 5470.73 1.52 5.06 5554.45 1.73 13.82 
5.23 803.18 0.22 5.24 862.55 0.27 22.73 
5.30 3931.35 1.09 5.29 3427.94 1.07 -1.83 
5.43 5709.42 1.58 5.36 4218.14 1.31 -17.09 
5.50 13055.46 3.62 5.49 13137.38 4.09 12.98 
5.69 10460.21 2.90 5.68 10219.93 3.18 9.66 
6.40 10934.14 3.03 6.40 9245.58 2.88 -4.95 
6.49 30069.85 8.33 6.49 22300.06 6.95 -16.57 
6.57 16379.10 4.54 6.56 14115.39 4.40 -3.08 
6.67 2541.04 0.70 6.67 1961.75 0.61 -12.86 
6.78 4882.91 1.35 6.78 6531.37 2.03 50.37 
6.87 1785.53 0.49 6.87 3890.22 1.21 146.94 
7.10 34004.87 9.42 7.08 27959.10 8.71 -7.54 
7.38 3322.77 0.92 7.37 2923.86 0.91 -1.09 
7.77 7428.59 2.06 7.76 6424.31 2.00 -2.91 
7.87 11243.69 3.11 7.87 9290.18 2.89 -7.07 
8.02 1440.78 0.40 8.02 1149.54 0.36 -10.00 
8.13 120220.40 33.3 8.12 107190.3 33.39 0.27 
8.22 5757.36 1.59 8.22 8274.56 2.58 62.26 
8.36 11871.07 3.29 8.36 11463.92 3.57 8.51 
8.42 32038.81 8.88 8.43 26462.51 8.24 -7.21 
8.54 1059.00 0.29 8.55 1062.59 0.33 13.79 
8.84 3981.17 1.10 8.85 3333.48 1.04 -5.45 
8.99 612.44 0.17 8.97 408.66 0.13 -23.53 
9.01 1143.11 0.32 9.02 1113.01 0.35 9.37 
9.11 9990.56 2.77 9.12 8593.14 2.68 -3.25 
10.12 10852.50 3.01 10.13 9926.36 3.09 2.66 
Total peak area 360990.02   321040.25   
% Change in total peak area*   -11.07 
WS: Withania somnifera, *denotes the percentage change in the peak area (%) of the Biofield Energy Treated sample with respect to the control sample. 
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Six chromatographic peaks out of the 27 peaks, only at the 
Rt of 6.87, 7.10, 7.87, 8.22, 8.54, and 9.11 minutes having 
higher peak area% are able to characterize with the help of 
mass spectra and afforded the respective ESI-MS spectra. A 
total of 18 withanolides were proposed along with GC-MS 
and NMR data (Figures 2 and 3). Compounds were proposed 
(Figures 2 and 3) from the mass of the molecular ion and its 
fragmentation pattern at the corresponding retention time 
(Table 2) along with the support of GC-MS and NMR data 
(Figures 4 & 5) of the crude extract according to the 
approach described in our recent literature [43]. 
Table 2. Compounds proposed from ESI-MS spectra of the control and Biofield Energy Treated ashwagandha root extract. 
Rt (min) ESI-MS (m/z) Proposed Compounds 
m/z peak Intensity % Change 
in Intensity Control Treated 
6.87 
650 [M + NH4]
+ 
Sitoindoside IX (1) 2.76e6 2.65e6 -3.99 
471 [M - 163]+ 
7.10 489 [M + H]+ 
β-Hydroxy-2, 3-dihydro-withanolide F (2) 
1.68e7 1.49e7 -11.31 
Viscosa lactone B (3) 
7.87 473 [M + H]+ 
24, 25-Dihydrowithanolide D (4) 
1.04e7 7.48e6 -28.08 
2, 3-Dihydrowithaferin A (5) 
27-Hydroxy withanolide A (6) 
(20S, 22R)-3α,6α-Epoxy-4β,5β, 27-trihydroxy-1-oxowitha-24-enolide (7) 
(20S, 22R)-4β,5β,6α, 27-Tetrahydroxy-1-oxo-with-2, 24-dienolide (8) 
8.22 471 [M + H]+ 
Withanolide A (9) 
7.06e7 6.63e7 -6.09 
Withaferine A (10) 
Withanone (11) 
Withanolide D (12) 
27-Hydroxy Withanolide B (13) 
5, 7, α-Epoxy-6α, 20α-dihydroxy-1-oxowitha-2, 24-Dienolide (14) 
5α, 17-Dihydroxy-6α, 7α-epoxy-1-oxo-witha-2, 24-dienolide (15) 
8.54 
505 [M + H]+ Ixocarpalactone A (16) 
5.26e6 2.51e6 -52.28 
488 [M - 16]+ Withanolide S (17) 
9.11 992 [M + H]+ Withanolide sulfoxide (18) 1.69e6 1.31e6 -22.49 
a denotes the percentage change of the Biofield Energy Treated sample with respect to the control sample. 
The LC-MS (Figure 2), GC-MS (Figure 4) and NMR 
(Figure 5) spectral analysis and following the literature [43] 
confirmed the presence of the withanolides. At Rt of 6.87 
minutes was sitoindoside IX (1) (Table 2 and Figure 2a) was 
proposed with the ammonium adduct mass peak at m/z 650 
[M + NH4]
+
 (calcd for C34H52NO11, 650) along with m/z 471 
[M – 163]
+ 
in the ESI-MS spectra of the control and Biofield 
Energy Treated sample. The peak area% of sitoindoside IX 
(1) was significantly increased by 146.94% in the Biofield 
Energy Treated sample as compared to the control sample 
(Table 1). It is a glycowithanolide, which is a brain 
antioxidants and can promote immunomodulation, 
neuroprotective and memory enhancing activity [43, 45]. β-
Hydroxy-2, 3-dihydro-withanolide F (2) or viscosa lactone B 
(3) was identified at Rt of 7.10 minutes with the molecular 
mass peak at m/z 489 (calcd for C28H40O7, 489) (Table 2 and 
Figures 2b and 3), which have the anti-inflammatory activity 
[12, 43]. The peak area% of it was decreased by 7.54% in the 
Biofield Energy Treated sample as compared to the control 
sample (Table 1). Similarly, the withanolides like 24, 25-
dihydrowithanolide D (4) or 2, 3-dihydrowithaferin A (5) or 
27-Hydroxy withanolide A (6) or (20S, 22R)-3α, 6α-Epoxy-
4β, 5β, 27-trihydroxy-1-oxowitha-24-enolide (7) or (20S, 
22R)- 4β, 5β, 6α, 27-Tetrahydroxy-1-oxo-with-2, 24-
dienolide (8) was proposed at the Rt of 7.87 minutes with 
molecular mass peak at m/z 473 [M + H]
+
 (calcd for 
C28H40O7, 489) (Table 2 and Figures 2c and 3). The % peak 
area was decreased by 7.02% in the Biofield Energy Treated 
sample compared to the control sample (Table 1). The 
withanolides like withanolide A (9) or withaferine A (10) or 
withanone (11) or withanolide D (12) or 27-hydroxy 
withanolide B (13) or 5, 7α-epoxy-6α, 20α-dihydroxy-1-
oxowitha-2, 24-dienolide (14) or 5α, 17β-dihydroxy-6α, 7α-
epoxy-1-oxo-witha-2, 24-dienolide (15) are proposed at Rt of 
8.22 minutes with molecular mass peak at m/z 471 [M + H]
+
 
(Table 2, Figures 2d and 3). The GC-MS (Figure 4) and 
NMR data (Figure 5) also supported the presence of any of 
these compounds 9-15. These compounds had lots of 
pharmacological activity and used for various disease [2-10, 
43]. The peak area% was increased significantly by 62.26% 
in the Biofield Energy Treated sample as compared to the 
treated sample (Table 1). Ixocarpalactone A (16) or 
withanolide S (17) proposed at the Rt of 8.54 minutes with 
molecular mass peak at m/z 505 [M + H]
+
 (calcd for 
C28H40O8, 505) (Table 2 and Figure 2e). The GC-MS (Figure 
4) and NMR data (Figure 5) also supported the presence of 
any of these compounds 16 or 17. The peak area% of 
ixocarpalactone A (16) or withanolide S (17) was increased 
significantly by 13.79% in the Biofield Energy Treated 
sample as compared to the control sample (Table 1). 
Ixocarpalactone A reported to be promising anti-tumor agent 
[43, 46, 47]. Similarly, the withanolide proposed at Rt of 9.11 
minutes m/z 992 [M + H]
+
 (calcd for C56H79O13S, 505) was 
withanolide sulfoxide (18) (Table 2 and Figure 2f). The GC-
MS (Figure 4) and NMR data (Figure 5) also supported the 
presence of any of this compound. The peak area% of 
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withanolide sulfoxide was decreased by 3.25% in the treated 
sample as compared to the control sample (Table 1). 
Withanolide sulfoxide is a bioactive molecule, effective as an 
anti-cancer agent [43, 48]. 
 
Figure 2. ESI-MS spectra (a-f) showing the possible withanolides (1-14) present in the control and Biofield Energy Treated sample of ashwagandha root 
extract. 
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The LC-MS analytical data of the control and Biofield 
Energy Treated sample revealed that the mass fragmentation 
pattern of both the control and Biofield Energy Treated 
samples were found almost similar. But, the mass peak 
intensity values were significantly decreased at the same 
retention time of the Biofield Energy Treated sample in the 
range of 3.99% to 52.28% compared with the control sample. 
This finding suggests that the natural isotopic abundance 
ratio of the identified phytoconstituents in the ashwagandha 
root extract might be altered due to the Consciousness 
Energy Healing Treatment. 
 
Figure 3. Possible important withanolides identified at Rt of 8.22 minutes from the control and Biofield Energy Treated root extract of ashwagandha. 
27 Mahendra Kumar Trivedi et al.:  Assessment of the Consciousness Energy Healing Treated Withania Somnifera   
(Ashwagandha) Root Extract Using LC-MS, GC-MS, and NMR Spectroscopy 
 
Figure 4. GC-MS spectra (a-e) of the control and Biofield Energy Treated ashwagandha root extract with the proposed fragmentation of withanolides. 
 
Figure 5. 1H NMR spectra of the control (a), Biofield Energy Treated (b), 13C NMR spectra of the control (c), and Biofield Energy Treated (d) Ashwagandha 
root extract. 
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4. Conclusions 
The current study infers that Consciousness Energy 
Healing Treatment (The Trivedi Effect
®
)
 
has the significant 
effect on the peak area% i.e. the relative concentration as 
well as the peak intensities of the phytoconstituents in 
ashwagandha root extract without affecting their structural 
properties. The LC-MS analysis revealed that the retention 
time of the phytoconstituents remained same in both the 
control and treated samples, whereas the peak area% at 
respective retention time was significantly altered. The peak 
area% of the treated sample at Rt of 5.06, 5.24, 5.49, 5.68, 
6.78, 6.87, 8.12, 8.22, 8.36, 8.55, 9.02, and 10.13 minutes 
were significantly increased in the range of 0.27% to 
146.94% compared to the control sample. In addition, the 
peak area% of the treated sample at Rt of 5.29, 5.36, 6.40, 
6.49, 6.56, 6.67, 7.08, 7.37, 7.76, 7.87, 8.02, 8.43, 8.85, 8.97, 
and 9.12 minutes were significantly decreased in the range of 
1.83% to 23.53% compared with the control sample. A total 
of 18 withanolides such as sitoindoside IX, viscosa lactone 
B, 24, 25-dihydrowithanolide D, withanolide A, withaferin 
A, withanone, withanolide D, ixocarpalactone A, withanolide 
S, withanolide sulfoxide, etc. were proposed with their 
structure from the molecular mass at m/z 650, 489, 473, 471, 
505, and 992 at retention times of 6.87, 7.10, 7.87, 8.22, 8.54, 
and 9.11 minutes with the help of GC-MS and NMR data of 
both the control and Biofield Energy Treated samples. The 
mass peak intensity values of at the same retention time in 
the Biofield Energy Treated sample was significantly 
decreased in the range of 3.99% to 52.28% compared with 
the control sample. The Energy of Consciousness Healing 
Treatment could be valuable for altering the concentration of 
the phytoconstituents in the ashwagandha root extract by 
modifying their intrinsic physicochemical properties, which 
might be helpful to improve the bioavailability of active 
constituents present in ashwagandha root extract that might 
provide better therapeutic response against various diseases 
various diseases such as allergies, diabetes mellitus, and 
septic shock; stress-related disorders like sleep disorder, 
anxiety, insomnia, Attention Deficit Disorder (ADD), 
depression, Attention Deficit Hyperactive Disorder (ADHD), 
brain frog, low libido, impotency, mental restlessness (mind 
chattering), lack of motivation, fear of the future, confusion, 
migraines, mood swings, headaches, forgetfulness, 
overwhelm, worthlessness, indecisiveness, loneliness, 
frustration, irritability, chronic fatigue, obsessive/compulsive 
behavior and panic attacks; inflammatory diseases and 
immunological disorders like Lupus, Hashimoto Thyroiditis, 
Systemic Lupus Erythematosus, Type 1 Diabetes, Asthma, 
Tuberculosis, Hepatitis, Chronic peptic ulcers, Chronic active 
hepatitis, Celiac Disease (gluten-sensitive enteropathy), 
Crohn's disease, Graves’ Disease, Addison Disease, 
Pernicious and Aplastic Anemia, Irritable Bowel Syndrome 
(IBS), Sjogren Syndrome, Multiple Sclerosis, Rheumatoid 
arthritis, Ulcerative colitis, Chronic periodontitis, Chronic 
sinusitis, Myasthenia Gravis, Diverticulitis, Atherosclerosis, 
Vasculitis, Dermatitis, Rheumatoid Arthritis, Alopecia 
Areata, Psoriasis, Scleroderma, Reactive Arthritis, 
Fibromyalgia, Chronic Fatigue Syndrome and Vitiligo; 
aging-related diseases like cardiovascular disease, arthritis, 
cancer, dementia, cataracts, osteoporosis, Alzheimer’s 
disease, diabetes, hypertension, glaucoma, Parkinson’s 
Disease, Huntington’s Disease, hearing loss, Prion Disease, 
Spinocerebellar Ataxia,, Motor Neuron Disease, 
Amyotrophic lateral sclerosis, Spinal muscular atrophy, 
Friedreich’s Ataxia and Lewy Body Disease, chronic 
infections and much more. 
Abbreviations 
DMSO: Dimethyl sulfoxide, EI: Electron impact, ESI: 
Electrospray ionization, LC-MS: Liquid chromatography-mass 
spectrometry, PDA: Photodiode Array, Rt: Retention time, 
UPLC: Ultra-performance liquid chromatography, GC-MS: 
Gas chromatography-mass spectrometry, m/z: Mass-to-charge 
ratio, NMR: Nuclear magnetic resonance spectroscopy. 
Acknowledgements 
The authors are grateful to GVK Biosciences Pvt. Ltd., 
Trivedi Science, Trivedi Global, Inc. and Trivedi Master 
Wellness for their assistance and support during this work. 
 
References 
[1] Kesarwani K, Gupta R (2013) Bioavailability enhancers of herbal 
origin: An overview. Asian Pac J Trop Biomed 3: 253-266. 
[2] Singh N, Bhalla M, Jager P, Gilca M (2011) An overview on 
ashwagandha: A rasayana (rejuvenator) of Ayurveda. Afr J 
Tradit Complement Altern Med 8: 208-213. 
[3] Kulkarni SK, Dhir A (2008) Withania somnifera: An Indian 
ginseng. Prog Neuropsychopharmacol Biol Psychiatry 32: 
1093-1105. 
[4] Dar NJ, Hamid A, Ahmad M (2015) Pharmacologic overview 
of Withania somnifera, the Indian ginseng. Cell Mol Life Sci 
72: 4445-4460. 
[5] Mir BA, Khazir J, Mir NA, Hasan T-ul, Koul S (2012) 
Botanical, chemical and pharmacological review of Withania 
somnifera (Indian ginseng): An Ayurvedic medicinal plant. 
Indian J Drugs Dis 1: 147-160. 
[6] Mishra LC, Singh BB, Dagenais S (2000) Scientific basis for 
the therapeutic use of Withania somnifera (Ashwagandha): A 
review. Altern Med Rev 5: 334-346. 
[7] Kumar V, Dey A, Hadimani MB, Marcović T, Emerald M 
(2015) Chemistry and pharmacology of Withania somnifera: 
An update. Tang (Humanitas Medicine) 5: e1. 
[8] Bolleddula J, Fitch W, Vareed SK, Nair MG (2012) 
Identification of metabolites in Withania sominfera fruits by 
liquid chromatography and high-resolution mass spectrometry. 
Rapid Commun Mass Spectrom 26: 1277-1290. 
29 Mahendra Kumar Trivedi et al.:  Assessment of the Consciousness Energy Healing Treated Withania Somnifera   
(Ashwagandha) Root Extract Using LC-MS, GC-MS, and NMR Spectroscopy 
[9] Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palazón J 
(2009) Steroidal lactones from Withania somnifera, an ancient 
plant for novel medicine. Molecules 14: 2373-2393. 
[10] Singh A, Duggal S, Singh H, Singh J, Katekhaye S (2010) 
Withanolides: Phytoconstituents with significant 
pharmacological activities. Int J Green Pharm 4: 229-237. 
[11] Chen LX, He H, Qiu F (2011) Natural withanolides: An 
overview. Nat Prod Rep 28: 705-740. 
[12] Budhiraja RD, Krishan P, Sudhir S (2000) Biological activity 
of withanolides. J Sci Ind Res 59: 904-911. 
[13] Stenger VJ (1999) Bioenergetic fields. Sci Rev Alternative 
Med 3. 
[14] Rogers, M (1989) Nursing: A Science of Unitary Human 
Beings. In J. P. Riehl-Sisca (ed.) Conceptual Models for 
Nursing Practice. 3rd edition. Norwark: Appleton & Lange. 
[15] Rosa L, Rosa E, Sarner L, Barrett S (1998) A close look at 
therapeutic touch. JAMA 279: 1005-1010. 
[16] Warber SL, Cornelio D, Straughn, J, Kile G (2004) Biofield 
energy healing from the inside. J Altern Complement Med 10: 
1107-1113. 
[17] Nelson LA, Schwartz GE (2005) Human biofield and 
intention detection: Individual differences. J Altern 
Complement Med 11: 93-101. 
[18] Nemeth L (2008) Energy and biofield therapies in practice. 
Beginnings. Summer 28: 4-5. 
[19] Koithan M (2009) Introducing complementary and alternative 
therapies. J Nurse Pract 5: 18-20. 
[20] Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) 
The potential impact of biofield treatment on human brain 
tumor cells: A time-lapse video microscopy. J Integr Oncol 4: 
141. 
[21] Trivedi MK, Branton A, Trivedi D, Nayak G, Gangwar M, 
Jana S (2015) Bacterial identification using 16S rDNA gene 
sequencing and antibiogram analysis on biofield treated 
Pseudomonas fluorescens. Clin Med Biochemistry Open 
Access 1: 101. 
[22] Trivedi MK, Branton A, Trivedi D, Nayak G, Bairwa K, Jana 
S (2015) Effect of biofield treatment on physical, thermal, and 
spectral properties of SFRE 199-1 mammalian cell culture 
medium. Advances in Biochemistry 3: 77-85. 
[23] Trivedi MK, Branton A, Trivedi D, Nayak G, Gangwar M, 
Jana S (2015) Antibiogram, biochemical reactions, and 
genotypic pattern of biofield treated Pseudomonas 
aeruginosa. J Trop Dis 4: 181. 
[24] Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, 
Jana S (2015) Evaluation of antibiogram, genotype and 
phylogenetic analysis of biofield treated Nocardia otitidis. 
Biol Syst Open Access 4: 143. 
[25] Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, 
Jana S (2015) Antimicrobial sensitivity, biochemical 
characteristics and biotyping of Staphylococcus 
saprophyticus: An impact of biofield energy treatment. J 
Women’s Health Care 4: 271. 
[26] Trivedi MK, Branton A, Trivedi D, Nayak G, Shettigar H, 
Mondal SC, Jana S (2015) Effect of biofield energy treatment 
on Streptococcus group B: A postpartum pathogen. J Microb 
Biochem Technol 7: 269-273. 
[27] Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) 
Effect of biofield treatment on antimicrobials susceptibility 
pattern of Acinetobacter baumannii - An experimental study. J 
Clin Diagn Res 3: 1. 
[28] Trivedi MK, Patil S, Tallapragada RM (2013) Effect of 
biofield treatment on the physical and thermal characteristics 
of vanadium pentoxide powders. J Material Sci Eng S 11: 
001. 
[29] Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak 
G, Latiyal O, Jana S (2015) Characterization of physical and 
structural properties of aluminum carbide powder: Impact of 
biofield treatment. J Aeronaut Aerospace Eng 4: 142. 
[30] Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak 
G, Latiyal O, Jana S (2015) The potential impact of biofield 
energy treatment on the atomic and physical properties of 
antimony tin oxide nanopowder. American Journal of Optics 
and Photonics 3: 123-128. 
[31] Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak 
G, Mishra RK, Jana S (2015) Biofield treatment: A potential 
strategy for modification of physical and thermal properties of 
gluten hydrolysate and ipomoea macroelements. J Nutr Food 
Sci 5: 414. 
[32] Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak 
G, Latiyal O, Jana S (2015) Potential impact of biofield 
treatment on atomic and physical characteristics of 
magnesium. Vitam Miner 3: 129. 
[33] Trivedi MK, Patil S, Shettigar H, Bairwa K, Jana S (2015) 
Effect of biofield treatment on spectral properties of 
paracetamol and piroxicam. Chem Sci J 6: 98. 
[34] Trivedi MK, Branton A, Trivedi D, Shettigar H, Bairwa K, 
Jana S (2015) Fourier transform infrared and ultraviolet-
visible spectroscopic characterization of biofield treated 
salicylic acid and sparfloxacin. Nat Prod Chem Res 3: 186. 
[35] Trivedi MK, Branton A, Trivedi D, Nayak G, Panda P, Jana S 
(2016) Gas chromatography-mass spectrometric analysis of 
isotopic abundance of 13C, 2H, and 18O in biofield energy 
treated p-tertiary butylphenol (PTBP). American Journal of 
Chemical Engineering 4: 78-86. 
[36] Trivedi MK, Branton A, Trivedi D, Nayak G, Bairwa K, Jana 
S (2015) Spectroscopic characterization of disodium hydrogen 
orthophosphate and sodium nitrate after biofield treatment. J 
Chromatogr Sep Tech 6: 282. 
[37] Trivedi MK, Branton A, Trivedi D, Nayak G, Sethi KK, Jana 
S (2016) Gas chromatography-mass spectrometry based 
isotopic abundance ratio analysis of biofield energy treated 
methyl-2-napthylether (Nerolin). American Journal of 
Physical Chemistry 5: 80-86. 
[38] Trivedi MK, Branton A, Trivedi D, Nayak G, Gangwar M, 
Jana S (2016) Molecular analysis of biofield treated eggplant 
and watermelon crops. Adv Crop Sci Tech 4: 208. 
[39] Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, 
Jana S (2015) Evaluation of biochemical marker - 
glutathione and DNA fingerprinting of biofield energy 
treated Oryza sativa. American Journal of BioScience 3: 
243-248. 
 American Journal of Physical Chemistry 2017; 6(2): 20-30 30 
 
[40] Chatterjee S, Srivastava S, Khalid A, Singh N, Sangwan RS, 
Sidhu OP, Roy R, Khetrapal CL, Tuli R (2010) 
Comprehensive metabolic fingerprinting of Withania 
somnifera leaf and root extracts. Phytochemistry 71: 1085-
1094. 
[41] Chaurasiya ND, Uniyal GC, Lal P, Misra L, Sangwan NS, Tuli 
R, Sangwan RS (2008) Analysis of withanolides in root and 
leaf of Withania somnifera by HPLC with photodiode array 
and evaporative light scattering detection. Phytochem Anal 
19: 148-154. 
[42] Musharraf SG, Ali A, Ali RA, Yousuf S, Rahman AU, 
Choudhary MI (2011) Analysis and development of structure-
fragmentation relationships in withanolides using an 
electrospray ionization quadropole time-of-flight tandem mass 
spectrometry hybrid instrument. Rapid Commun Mass 
Spectrom 25: 104-114. 
[43] Trivedi MK, Panda P, Sethi KK, Jana S (2016) Metabolite 
profiling of Withania somnifera roots hydroalcoholic extract 
using LC-MS, GC-MS and NMR spectroscopy. Chem 
Biodivers (Article in press) doi: 10.1002/cbdv.201600280. 
[44] https://www.scribd.com/document/220440935/Theory-of-
HPLC-Quantitative-and-Qualitative-HPLC. 
[45] Ghosal S, Lal J, Srivastava RS, Bhattacharya SK, Upadhyay 
SN, Jaiswal AK, Chattopadhyay U (1989) Immunomodulatory 
and CNS effects of sitoindosides IX and X, two new 
glycowithanolides from Withania somnifera. Phytother Res 3: 
201-206. 
[46] Kinghorn AD, Su BN, Lee D, Gu JQ, Pezzuto JM (2003) 
Cancer chemopreventive agents discovered by activity-guided 
fractionation: An update. Current Organic Chemistry 7: 213-
226. 
[47] Mulabagal V, Subbaraju GV, Rao CV, Sivaramakrishna C, 
Dewitt DL, Holmes D, Sung B, Aggarwal BB, Tsay HS, Nair 
MG (2009) Withanolide sulfoxide from Aswagandha roots 
inhibits nuclear transcription factor-κB, cyclooxygenase and 
tumor cell proliferation. Phytother Res 23: 987-992. 
[48] Subbaraju GV, Vanisree M, Rao CV, Sivaramakrishna C, 
Sridhar P, Jayaprakasam B, Nair MG (2006) 
Ashwagandhanolide, a bioactive dimeric thiowithanolide 
isolated from the roots of Withania somnifera. J Nat Prod 69: 
1790-1792. 
 
